Sleep Apnea Devices Market

Sleep Apnea Devices Market Size

The global sleep apnea devices market is estimated to be worth $13.5 billion in 2024 and is anticipated to grow at a CAGR of 4.94% during the forecast period from 2023 to 2035.  

The new research study consists of industry trends, detailed market analysis, patent analysis, clinical trial analysis, funding and investment analysis and partnerships and collaborations analysis. The growth in the sleep apnea devices market share over the next decade is likely to be the result of anticipated increase in patient population and rise in the demand for sleep apnea devices for sleep apnea treatment.

To learn more about this report, request a free sample copy

Sleep apnea, used interchangeably with sleep apnoea, is one of the serious sleep disorders characterized by repeated start or stop in breathing during sleep. These interruptions in sleep can last up to several minutes. Sleep apnea can be broadly categorized into three types, obstructive sleep apnea, central sleep apnea and complex sleep apnea. Obstructive sleep apnea and central sleep apnea are the most common types of sleep apnea with similarity in symptoms, which include loud snoring, morning headache, excessive daytime sleepiness and dry mouth.

Sleep apnea is often an underdiagnosed condition that can affect all age groups. According to a study, obesity and excess weight is the most common cause of sleep apnea in adults. Additionally, modern lifestyle-related risk factors, such as smoking, alcohol consumption, lack of physical activity and psychological stress play a crucial role in the rapidly increasing prevalence of sleep apnea. As a result, medical experts are extensively focusing on developing effective, safe and versatile sleep apnea diagnosis and treatment options. Currently, several therapeutic devices are being employed for the treatment of sleep apnea. Owing to the rising disease burden of sleep apnea, as well as the ongoing research and development efforts to develop advanced obstructive sleep apnea medical devices, the sleep apnea devices market is anticipated to witness steady market growth during the forecast period.

Market Share Insights

The sleep apnea devices market research report presents an in-depth analysis of the various companies that are engaged in the global sleep apnea industry, across different segments, as defined in the table below:

Sleep Apnea Devices Market: Report Attributes / Market Segmentations

Key Report Attribute	Details
Historical Trend	2018-2022
Base Year	2023
Forecast Period	2024-2035
Sleep Apnea Devices Market 2024	$ 13.05 Billion
CAGR	4.94%
Product Type	Sleep Apnea Medical Devices Sleep Apnea Drug Therapies
Type of Diagnostic Device	Polysomnography Devices Home Sleep Apnea Testing Devices
Type of Therapeutic Device	Positive Airway Pressure Devices Oral Devices Implantable Devices
Type of Positive Airway Pressure Device	CPAP Machine BiPAP Machines APAP Machines Other Machines
Route of Administration	Oral Therapies Subcutaneous Therapies
Key Geographical Regions	North America Europe Asia-Pacific Rest of the World
Key Companies Profiled	Acurable Advanced Brain Monitoring Airway Management Apnimed Bayer Belun Technology BRAEBON Medical Cadwell Desitin Pharma Drive DeVilbiss Healthcare Eli Lilly and Company Hunan Ventmed Medical Technology Incannex Healthcare Löwenstein Medical Nihon Kohden Nox Medical Oventus Medical Philips React Health ResMed SciSparc Sibelmed Somnetics International inc  SomnoMed Sunrise Topson Medical Vyaire Medical Wellue Whole You ZOLL Itamar (Full list of 110+ companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Market Landscape Analysis Clinical Trial Analysis Partnership and Collaboration Analysis Funding and Investment Analysis Patent Analysis Market Forecast an Opportunity Analysis

One of the key objectives of this market report was to estimate the current sleep apnea devices market share, opportunity and the future growth potential of the sleep apnea devices market, over the forecast period. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the sleep apnea devices market evolution during the forecast period 2024-2035.

The sleep apnea devices market report also features the likely distribution of the current and forecasted opportunity within the sleep apnea devices market across various segments, such as product type (sleep apnea medical devices and drug therapies), type of diagnostic device (polysomnography devices and home sleep apnea testing devices), type of therapeutic device (positive airway pressure devices, oral devices and implantable devices), type of positive airway pressure device (CPAP machine, BiPAP machines, APAP machines and other machines), route of administration (oral therapies and subcutaneous therapies) and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World).

In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Segmental Overview

Market Share by Product Type

The global sleep apnea market highlights the distribution of this segment across different types of products, such as sleep apnea medical devices and drug therapies. The sleep apnea devices market segment occupies the highest share in 2024 and is expected to witness substantial growth in the coming years.

Market Share by Type of Diagnostic Device

The global sleep apnea diagnostic devices market is categorized into polysomnography devices and home sleep apnea testing devices. The home sleep apnea testing devices segment occupies the highest sleep apnea devices market share for diagnosis in 2024 and expected to dominant during the forecast period. This can be primarily attributed to the fact that such devices offer a convenient and cost-effective way to monitor and diagnose sleep apnea from the comfort of their homes.

Market Share by Type of Therapeutic Device

The global sleep apnea therapeutic devices market is segmented into positive airway pressure devices, oral devices and implantable devices. Owing to their comfortable and convenient nature oral devices are likely to grow at a higher CAGR as compared to other devices in the coming years.

Market Share by Key Geographical Regions

This segment highlights the distribution of sleep apnea drugs market and sleep apnea devices market share across various geographies, such as North America, Europe, Asia-Pacific and Rest of the World. According to our projections, the sleep apnea devices market in North America is likely to capture majority (70%) of the market share, and this trend is unlikely to change in the future. It is worth highlighting that the market in Asia-Pacific is expected to grow at a relatively healthy CAGR (9%), during the period 2024-2035.

Key Market Insights

The “Sleep Apnea Devices Market - Distribution by Product Type (Sleep Apnea Medical Devices and Drug Therapies), Type of Diagnostic Device (Polysomnography Devices and Home Sleep Apnea Testing Devices), Type of Therapeutic Device (Positive Airway Pressure Devices, Oral Devices and Implantable Devices), Type of Positive Airway Pressure Device (CPAP Machine, BiPAP, APAP  and Other Devices), Route of Administration (Oral Therapies and Subcutaneous Therapies) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, sleep apnea devices market share, market size, market analysis, market forecast and future opportunities for the sleep apnea companies involved in the development of sleep apnea medical devices and sleep apnea drugs. The sleep apnea devices market research report highlights the efforts of several sleep apnea device manufacturers and sleep apnea therapy developers engaged in this rapidly emerging market segment of the pharmaceutical industry. Key takeaways of the sleep apnea devices market report are briefly discussed below.

Rising Prevalence of Obstructive Sleep Apnea and Central Sleep Apnea

Sleep apnea is an underrecognized medical condition that is more common in men than women and prevalence of sleep apnea tend to rise with age in the general population. It is estimated that nearly 1 billion people have mild to severe sleep apnea globally, however, a substantial portion of this population remains undiagnosed. In Europe, sleep apnea has emerged as one of the key public health problems. In fact, nearly 90 million (22.7%) people have moderate to severe obstructive sleep apnea in Europe. Similarly, around 7% of the total population and 60% of the geriatric population aged 65 and above is suffering from obstructive sleep apnea in the US. It is worth highlighting that improved detection and diagnosis of sleep apnea has also contributed to the growing number of reported cases of this clinical condition.

Competitive Landscape of Sleep Apnea Device Manufacturers

The sleep apnea device manufacturers landscape features over 100 companies offering a range of sleep apnea medical devices, including continuous positive airway pressure machines (CPAP machine), bilevel positive airway pressure machines (BiPAP), auto-adjusting pressure machines (APAP), oral devices, implantable devices, contactless devices, adaptive servo ventilation, expiratory positive airway pressure devices, home sleep apnea test devices and polysomnography devices. Notably, the majority of the sleep apnea medical devices can be used in home care setting for the diagnosis and treatment of sleep apnea, with an aim to enhance the overall experience of end user. Some examples of obstructive sleep apnea medical devices include O2Vent Optima Mini, aura6000™, AirSense™ 11 CPAP and Bongo Rx. Overall, the market landscape of sleep apnea medical device manufacturers is well-fragmented, featuring the presence of small, mid-sized, and large sleep apnea companies located in different geographical regions.

It is interesting to note that around 50% of these sleep apnea device manufacturers are located in North America, followed by Europe. Within North America, US and Canada emerged as the hubs for sleep apnea device manufacturers. It is worth highlighting that Appscent Medical, an Israel based company, is developing an advanced artificial intelligence-based home care medical device for contactless detection and treatment of sleep apnea, which is expected to revolutionize the sleep apnea treatment in the coming years. In addition, Resmed captures the significant sleep apnea devices market share for both diagnostic and treatment devices. Furthermore, amidst the recent initiatives undertaken to develop more convenient treatment options for this medical condition, sleep apnea nasal devices have emerged as one of the most suitable options, having demonstrated the capability to treat sleep apnea.

Competitive Landscape of Sleep Apnea Drug Therapy Developers

Sleep apnea drugs market features the presence of close to 25 industry and non-industry players developing / evaluating drug therapies for sleep apnea treatment. Over 35 sleep apnea drug therapies are currently being evaluated in different phases of clinical studies, either as monotherapies or in combination with other drugs for the treatment of obstructive sleep apnea and central sleep apnea. It is worth highlighting that, in June 2022, Apnimed received fast track designation from the USFDA for its novel oral pharmacologic combination for sleep apnea treatment. Further, in October 2022, Eli Lilly and Company received the fast-track designation for its single novel molecule tirzepatide for sleep apnea treatment.

Sleep Apnea Devices Market Trends Analysis: Increase in Funding and Patent Activity Reflect the Rising Interest in this Industry

In the past four years, close to USD 1.6 billion have been invested by various investors across the globe in sleep apnea companies engaged in the sleep apnea devices market. These companies raised majority of the funds through other equity. It is worth highlighting that LivaNova raised a significant capital amount (USD 595 million) through other equity. The company has planned to use this amount to advance its neurostimulator therapeutic device for sleep apnea treatment.

Additionally, over 1,600 patents focused on sleep apnea have been granted / filed in the past four years, indicating the substantial efforts made by researchers engaged in this domain. Most of the patents have been filed for the advancement of sleep apnea medical devices.

Sleep Apnea Devices Market Analysis: Sleep Apnea Therapeutic Devices Hold Majority Market Share

The global sleep apnea devices market is estimated to be worth USD 13.5 billion in 2024. The market growth is expected to be driven by the growing geriatric population, rising demand for sleep apnea therapeutic devices leading to a CAGR of 4.61% and carve out a significant sleep apnea devices market share over the forecast period.

Regional Analysis: North America Emerged as the Hub of Sleep Apnea Medical Devices and Sleep Apnea Treatment; Asia Pacific to be the Fastest Growing Market

Presently, North America capture 70% of the market share of the overall sleep apnea devices market. In the recent years, demand for sleep apnea devices has witnessed a tremendous increase in North America. Further, it is worth highlighting that, owing to the rising demand for sleep apnea devices and anticipated drug approvals, market in Asia Pacific is likely to grow at a higher CAGR as compared to other regions in the coming years.

Key Sleep Apnea Companies Involved in Sleep Apnea Market

Examples of key sleep apnea companies in sleep apnea market (the complete list of companies is available in the full report) include Acurable, Advanced Brain Monitoring, Airway Management, Apnimed, Bayer, Belun Technology, Braebon Medical, Cadwell, Desitin Pharma, Drive DeVilbiss Healthcare, Eli Lilly and Company, Fisher Paykel, Hunan VentMed Medical Technology, Incannex Healthcare, Löwenstein Medical, Natus Medical, Nox Medical, Oventus Medical, Philips, React Health, ResMed, SciSparc, Sibelmed, Somnetics International inc, SomnoMed, Sunrise, Topson Medical, Vyaire Medical, Wellue, Whole You and ZOLL Itamar. This global sleep apnea market research report includes an easily searchable excel database of all the companies that have capability to offer sleep apnea devices (such as cpap machine) or engaged in developing sleep apnea drugs worldwide.

Report Coverage

The sleep apnea devices market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:

• A preface provides an introduction to the full report, Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035.
• An outline of the systematic research methodology adopted to conduct the study on sleep apnea devices market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
• An overview of economic factors that impact the overall sleep apnea devices market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the key insights captured during our research, offering a high-level view on the current landscape of the sleep apnea medical devices and sleep apnea drug therapies and its likely evolution in the short to mid and long term.
• A general overview of sleep apnea, highlighting details on different types of sleep apnea and its impact on health. It also features the various devices available for the diagnosis and treatment of sleep apnea. Further, it provides information on the drug therapies being investigated for sleep apnea.
• A comprehensive assessment of the overall market landscape of diagnostic devices for detection of sleep apnea, based on several relevant parameters, such as type of device (polysomnography devices and home sleep apnea testing devices), physiological parameters monitored (heart rate, blood oxygen level, body position, snoring, chest motion, sleep stages and others), type of sleep apnea diagnosed (obstructive sleep apnea, central sleep apnea and complex sleep apnea), device connectivity (bluetooth, cellular, wi-fi and others / undisclosed), target patient segment (adults, children and elderly adults), end user (home care settings and individuals, hospitals / clinics and others) and price. In addition, the chapter features information on various device developers, along with analysis based on multiple parameters, such as year of establishment, company size and location of headquarters.
• A detailed assessment of the overall market landscape of the sleep apnea therapeutic devices for sleep apnea treatment, based on several relevant parameters, such as type of sleep apnea treated (obstructive sleep apnea, central sleep apnea and complex sleep apnea), therapeutic principle (airway pressure, jaw and tongue stabilization, neurostimulation, physiological monitoring and others), type of device (oral devices, AutoPAP, BiPAP, CPAP, implanted devices, adaptive servo ventilation, EPAP, contactless devices and others), type of mask (nasal masks, full face masks and nasal pillow masks), type of treatment, device connectivity (bluetooth, cellular, wi-fi and others / undisclosed), type of storage offered (SD card, cloud platform, USB drive and web portal), target patient segment (adults, elderly adults and children), end user (home care settings and individuals, hospitals / clinics and others) and price. In addition, the chapter features information on various device developers, along with analysis based on multiple parameters, such as year of establishment, company size, location of headquarters and most active players (in terms of number of products developed). 
• A detailed overview of the current market landscape of the sleep apnea drug therapies currently under development for sleep apnea treatment, based on several relevant parameters, such as phase of development (phase III, phase II and phase I), type of therapy (monotherapy and combination therapy), route of administration (oral, nasal, intravenous and subcutaneous), number of doses (multiple doses and single dose) and target patient segment (adults and elderly adults, adults and children). In addition, the chapter features information on various therapy developers, along with analysis based on multiple parameters, such as year of establishment, company size and location of headquarters. 
• Elaborate profiles of prominent companies (shortlisted based on product portfolio strength) engaged in sleep apnea market. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and leadership team), details related to product portfolio, recent developments and an informed future outlook.
• An insightful clinical trial analysis of completed / ongoing clinical trials related to sleep apnea, based on various relevant parameters, such as trial registration year, trial phase, trial status, type of sponsor / collaborator, study design, trial focus area, number of patients enrolled, most active players (based on the number of clinical trials conducted) and geography.
• A detailed analysis of the partnerships inked between stakeholders in sleep apnea market, since 2017, covering acquisitions, product / technology integration agreements, distribution agreements, service alliances, commercialization agreements, research agreements and other relevant agreements.
• An analysis of the funding and investments made in sleep apnea companies, since 2019, through seed financing, venture capital financing, IPOs, secondary offerings, grants / awards, private placements, other equity and debt financing, at various stages of development of such companies, based on several parameters, such as year of investment, amount invested, type of funding, investment focus area, leading players, key investors, and geographical analysis.
• An in-depth analysis of various patents that have been filed / granted related to sleep apnea, since 2019, taking into consideration parameters, such as type of patent, patent publication year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant, leading industry players (in terms of number of patents filed) leading non-industry players (in terms of number of patents filed) and leading individual assignees (in terms of number of patents filed). In addition, the chapter includes a detailed patent benchmarking analysis, highlighting key stakeholders and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations). 
• An in-depth analysis of the factors that can impact the growth of sleep apnea devices market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
• A detailed estimate of the current sleep apnea devices market size, opportunity and the future growth potential of the sleep apnea market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the sleep apnea devices market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
• A detailed projections of the current and future sleep apnea market across different type of product, such as sleep apnea medical devices and drug therapies.
• A detailed estimate of the current market size, opportunity and the future growth potential of the sleep apnea diagnostic devices market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea diagnostic devices market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
• A detailed projections of the current and future sleep apnea diagnostic devices market across different types of devices, such as polysomnography device and home sleep apnea testing device.
• A detailed projection of the current and future sleep apnea diagnostic devices market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
• A detailed estimate of the current market size, opportunity and the future growth potential of the sleep apnea therapeutic devices market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea therapeutic devices market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
• A detailed projections of the current and future sleep apnea therapeutic devices market across different types of devices, such as PAP devices, oral devices and implantable devices.
• A detailed projection of the current and future sleep apnea therapeutic devices market across different types of PAP devices, such as APAP, BiPAP, CPAP and other devices.
• A detailed projections of the current and future sleep apnea therapeutic devices market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
• A detailed estimate of the future growth potential of the sleep apnea drug therapies market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution during the forecast period. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea therapies market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
• A detailed projections of the future sleep apnea drug therapies market across different routes of administration, such as oral therapies and subcutaneous therapies.
• A detailed projections of the future sleep apnea drug therapies market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.

Recent Developments in Sleep Apnea Devices Market

Several recent developments have taken place in the field of sleep apnea devices market, some of which have been outlined below. These developments, even if they took place post the release of our sleep apnea devices market report, substantiate the overall sleep apnea devices market trends that we have outlined in our analysis.

• In June 2023, the US-based Inspire Medical Systems received an expanded FDA approval for its neurostimulation technology based medical device, an alternative of traditional CPAP machine for sleep apnea treatment. This expanded approval is expected to enable the company to offer its device to patients with severe obstructive sleep apnea.
• In June 2023, Fisher Paykel signed a product / technology integration agreement with VGM & Associate, a US based hospital. Under the terms of the agreement, Fisher Paykel announced its plans to use myAirvo line of product to support VGM members.

Author(s): Pemba Lahmo, Ajay Kumar Sharma, Usama Bin Firoj

Frequently Asked Questions

Question 1: What is sleep apnea?

Answer: Sleep apnea is a serious yet common medical condition in which breathing repeatedly stops during sleep and may result in low levels of oxygen in patient’s body.

Question 2: What are the three types of sleep apnea?

Answer: There are three main types of sleep apnea including obstructive sleep apnea, central sleep apnea and complex sleep apnea.

Question 3: What is the cause of sleep apnea?

Answer: Sleep apnea is primarily caused by the relaxation of throat muscles and tissues during sleep, which obstructs the airway.

Question 4: How do you fix sleep apnea?

Answer: Currently, no treatment option is available for this chronic condition. However, there are certain devices that help in managing this condition, such as positive airway pressure device, oral device and implantable device.

Question 5: How many CPAP machine users are there in the US?

Answer: It is estimated that around 8 million people in the US use CPAP machine.

Question 6: How big is the sleep apnea devices market?

Answer: The global market size of sleep apnea devices market is estimated to be worth USD 13.5 billion in 2024.

Question 7: What is the market growth for sleep apnea devices market?

Answer: The global sleep apnea devices market is estimated to grow at an annualized CAGR of 4.61% during the forecast period.

Question 8: Who is the market leader in CPAP?

Answer: Presently, ResMed captures 48% of the total OSA devices market.

Question 9: How much is the CPAP industry worth?

Answer: The global market size of CPAP industry is estimated to be USD 3.50 billion in 2024.

Question 10: Who are the key players in sleep apnea drug therapies market?

Answer: Apnimed and Eli Lilly and Company are the key players engaged in the sleep apnea drug therapies market.